Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Open Lending Q1 2026 Earnings Call - Certified Loan Volume Beats Guidance as Profitability Levers Tighten
Open Lending delivered Q1 2026 results that prioritize quality over quantity, with certified loan volume of 21,064 surpassing the top end of guidance. Management intentionally pulled back from higher-...
- Certified loan volume reached 21,064 in Q1 2026, exceeding the top end of quarterly guidance despite an 18% year-over-year decline, driven by a deliberate shift away from higher-risk credit segments.
- Per-loan unit economics improved 30% year-over-year to $363, up from $278 in Q1 2025, reflecting the impact of 2025 underwriting refinements and pricing adjustments.
- The 2026 vintage was booked at a conservative 70% loss ratio, down from the 72.5% applied to 2025 vintages, signaling improved credit quality and underwriting precision.
- +7 more takeaways
Malibu Boats Q3 2026 Earnings Call - Legacy Business Outperforms as Saxdor Acquisition Begins to Pay Off
Malibu Boats delivered a quarter of strategic acceleration and financial resilience, with legacy revenue and adjusted EBITDA surpassing guidance despite a 17% drop in unit volume. The company’s discip...
- Legacy net sales of $212.6 million exceeded guidance, driven by a 12.1% increase in net sales per unit to $179,000 on favorable model and segment mix.
- Consolidated net sales rose 3.1% to $235.7 million, with Saxdor contributing $23.1 million in its first full month.
- Adjusted EBITDA reached $22.7 million, with consolidated margin at 9.6%, up 420 basis points sequentially as centralized sourcing benefits flowed through.
- +7 more takeaways
FiscalNote Holdings Q1 2026 Earnings Call - Free Cash Flow Milestone and Prediction Market Bet
FiscalNote Holdings reported Q1 2026 results that met revenue guidance but highlighted a structural shift toward profitability and cash generation. The company posted $20 million in revenue and $1 mil...
- Q1 2026 GAAP revenue came in at $20 million, squarely within the $20 million to $21 million guidance range.
- Adjusted EBITDA was $1 million, meeting guidance, with an adjusted EBITDA margin of 5.1%, down from 10.1% in Q1 2025 due to revenue declines outpacing immediate cost savings.
- Annual Recurring Revenue (ARR) declined to $75.7 million from $84.1 million at year-end, primarily due to the loss of several large customers who did not transition to the new PolicyNote platform and federal spending headwinds.
- +9 more takeaways
Informa TechTarget Q1 2026 Earnings Call - EBITDA Surges 27% as AI Search Shifts Buyer Behavior
Informa TechTarget reported Q1 2026 revenue of $106 million, up 2% year-over-year, while adjusted EBITDA jumped 27% to $7.4 million. The company is capitalizing on the shift from search-driven to AI a...
- Revenue reached $106 million, a 2% year-over-year increase, with adjusted EBITDA surging 27% to $7.4 million, reflecting strong margin expansion.
- The company shifted to two operating segments: Brand to Demand (70% of revenue, up 5% YoY) and Intelligence and Advisory (30% of revenue, down 4% YoY due to weaker consulting demand).
- AI-driven search disruption is reshaping buyer behavior, but conversion rates from AI answer engines to membership are higher than traditional search, supporting low single-digit membership growth.
- +7 more takeaways
Axcelis Technologies Q1 2026 Earnings Call - Memory Momentum Offsets Mature Node Digestion
Axcelis reported Q1 2026 revenue of $199 million and EPS of $0.72, slightly beating expectations despite a $5 million one-time customer settlement headwind. The company’s CS&I business delivered stron...
- Q1 2026 revenue came in at $199 million, with EPS of $0.72, slightly above guidance after accounting for a $5 million one-time customer settlement headwind.
- CS&I revenue grew over 30% year-over-year, exceeding management expectations and reflecting stronger service, consumables, and system upgrade demand.
- Memory market system shipments reached their highest level since Q4 2023, with meaningful sequential increases in both revenue and bookings driven by AI-related DRAM capacity investments.
- +7 more takeaways
"Absci" Q1 2026 Earnings Call - Prolactin Pipeline Expansion and Oncology Pivot
Absci's Q1 2026 update centers on a strategic pivot away from oncology toward a concentrated focus on its prolactin receptor pipeline, led by the lead asset ABS-201 for androgenetic alopecia (AGA) and...
- Absci is pivoting its strategic focus away from oncology, halting internal development of assets ABS-301 and ABS-501 to concentrate capital and resources on its prolactin receptor pipeline.
- The company announced a new anti-prolactin receptor antibody, ABS-202, for an undisclosed immune-inflammatory (I&I) indication, expanding its early-stage pipeline beyond AGA and endometriosis.
- ABS-201 for androgenetic alopecia (AGA) remains the lead asset, with the Phase I/IIa headline trial on track and all four single ascending dose cohorts fully dosed.
- +7 more takeaways
ZipRecruiter Q1 2026 Earnings Call - AI-Driven Engagement Surges Amid Muted Hiring Cycle
ZipRecruiter delivered a resilient Q1 2026, posting $107.5 million in revenue and beating guidance on both the top and bottom lines. The company is leveraging its next-generation AI matching engine an...
- Revenue of $107.5 million beat the midpoint of guidance, representing a 2% year-over-year decline and a 4% sequential decline driven by post-holiday seasonality and a soft macro backdrop.
- Adjusted EBITDA came in at $9.7 million, a 9% margin that significantly exceeded the high end of the guidance range, up from 5% in Q1 2025.
- ZipRecruiter launched its next-generation AI search and matching engine, resulting in a 37% increase in application volume for job seekers exposed to the new algorithm.
- +7 more takeaways
BridgeBio Pharma Q1 2026 Earnings Call - ATTRUBY Surges 392% as BridgeBio Launches $500M Buyback Amid Pipeline Readiness
BridgeBio Pharma delivered a blockbuster Q1 2026, with ATTRUBY net revenue skyrocketing 392% year-over-year to $180.6 million. The drug is on track to become a $4 billion franchise, buoyed by accelera...
- ATTRUBY Q1 2026 net revenue surged 392% YoY to $180.6 million, driven by accelerating first-line market share gains and new patient starts exceeding 6,100 per quarter.
- Real-world evidence is mounting: a Nevada system study showed statistically significant outcome improvements for acoramidis versus tafamidis, and a medRxiv paper indicates a 43% reduction in diuretic intensification.
- Management now forecasts ATTRUBY to be a $4 billion drug, with confidence that growth will extend well past the 2031/2032 patent cliff due to Part D’s continuous plan structure and clinical differentiation.
- +7 more takeaways
VTEX Q1 2026 Earnings Call - AI-Native Commerce Suite Drives Margin Expansion Amid Brazil Headwinds
VTEX reported mixed results for Q1 2026, with top-line growth moderating due to persistent macro headwinds in Brazil, but profitability and cash generation surged. GMV reached $5.1 billion, up 17% yea...
- GMV reached $5.1 billion in Q1 2026, representing 17% year-over-year growth in USD, though FX-neutral growth moderated to 7% due to persistent macro headwinds in Brazil.
- Non-GAAP operating income doubled to $10.6 million, reflecting a 17.4% operating margin and demonstrating significant operational leverage despite slower top-line growth.
- Free cash flow surged to $13.3 million, doubling year-over-year and achieving a robust 21.9% free cash flow margin, underscoring the company's disciplined capital allocation.
- +7 more takeaways
Expedia Group Q1 2026 Earnings Call - Margin Expansion and AI Strategy Drive Strong Performance
Expedia Group delivered a robust Q1 2026, exceeding expectations with 13% gross bookings growth, 15% revenue growth, and a near 6-point expansion in EBITDA margins to 15.8%. The quarter was marked by ...
- Gross bookings grew 13% to $35.5 billion, with revenue up 15% to $3.4 billion, beating the high end of guidance.
- Adjusted EBITDA margin expanded nearly 6 points year-over-year to 15.8%, marking the highest Q1 margin in 15 years.
- Consumer bookings grew 10%, the fastest pace in 12 quarters, driven by strong performance across Expedia, Vrbo, and Hotels.com.
- +7 more takeaways